Minireviews
Copyright ©The Author(s) 2021.
Artif Intell Gastrointest Endosc. Aug 28, 2021; 2(4): 168-178
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.168
Table 1 Summary of the studies utilizing endoscopic ultrasound elastography for evaluating pancreatic lesions
Ref.
Population of the study
Key findings
Giovannini et al[13], 200624 patients with pancreatic masses. Sensitivity 100% and specificity 67% in diagnosing malignant lesions.
Sensitivity 100% and specificity 50% in diagnosing malignant invasion of lymph nodes.
Uchida et al[6], 2009Phase 1: pancreatic cancer (5 subjects), endocrine tumor (2 subjects), chronic pancreatitis (5 subjects), intraductal papillary mucinous neoplasm.Diagnostic performance of real-time tissue elastography mode for diagnosing malignancy: Operator vs another reviewer
Sensitivity: 64.3% vs 60.7%.
Specificity: 88% vs 88%.
Positive predictive value: 85.7% vs 85%.
Phase 2: 53 consecutive subjects with pancreatic lesions visible on B-mode images.Negative predictive value: 68.8% vs 66.7%.
Iglesias-Garcia et al[14], 2009130 consecutive patients with solid pancreatic masses vs 20 subjects with normal pancreases.Diagnostic performance of EUS elastography in diagnosing malignancy
Sensitivity: 100%.
Specificity: 85.5%.
Positive predictive value: 90.7%.
Negative predictive value: 100%.
Overall accuracy: 94%.
Hirche et al[4], 200870 patients with unclassified solid pancreatic lesions vs 10 subjects with healthy pancreas.Diagnostic performance of EUS elastography in predicting the nature of pancreatic lesions
Sensitivity: 41%.
Specificity: 53%.
Accuracy: 45%.
Janssen et al[15], 200720 patients with chronic pancreatitis vs 33 patients with focal pancreatic lesions vs 20 subjects with normal pancreas.Diagnostic performance of EUS elastography in diagnosing chronic pancreatitis
Sensitivity: 65.9%.
Specificity: 56.9%.
Accuracy: 60.2%.
Diagnostic performance of EUS elastography in diagnosing focal pancreatic lesions
Sensitivity: 93.8%.
Specificity: 65.4%.
Accuracy: 73.5%.
Diagnostic performance of EUS elastography in differentiating pancreatic adenocarcinoma and inflammatory pancreatic masses
Li et al[16], 2013Meta-analysis of 10 studies with 781 patients. Diagnostic performance of EUS elastography in differentiating pancreatic adenocarcinoma and inflammatory pancreatic masses
AUC: 0.8227.
In studies with color pattern as the diagnostic standard
Sensitivity: 99%.
Specificity: 76%.
Positive likelihood ratio: 3.36.
Negative likelihood ratio: 0.03.
Diagnostic odds ratio: 129.96.
In studies with hue histogram as the diagnostic standard
Sensitivity: 92%.
Specificity: 68%.
Positive likelihood ratio: 2.84.
Negative likelihood ratio: 0.12.
Diagnostic odds ratio: 24.69.
Xu et al[17], 2013Meta-analysis of 9 studies.Diagnostic performance of EUS elastography in differentiating benign and malignant pancreatic masses
In studies with qualitative color pattern as the diagnostic standard
Sensitivity: 99%.
Specificity: 74%.
AUROC: 0.9624.
In studies with quantitative hue histogram value as the diagnostic standard
Sensitivity: 85%-93%.
Specificity: 64%-76%.
Mei et al[18], 2013Meta-analysis of 13 studies with 1044 patients. Diagnostic performance of EUS elastography in differentiating benign and malignant solid pancreatic masses
Sensitivity: 95%.
Specificity: 67%.
Diagnostic odds ratio: 42.28.
Altonbary et al[19], 201997 patients with malignant lesions vs 19 patients with benign lesionsDiagnostic performance of combined elasticity score and strain ratio in differentiating benign and malignant pancreatic lesions (cut-off point: 7.75)
Sensitivity: 99%.
Specificity: 94.6%.
Positive predictive value: 98%.
Negative predictive value: 98.5%.
Accuracy: 97%.
Ignee et al[20], 2018218 patients with solid pancreatic lesions sized ≤ 15 mm and a definite diagnosis. Diagnostic performance of EUS elastography with high stiffness of the lesion in diagnosing malignancy
Sensitivity: 84%.
Specificity: 67%.
Positive predictive value: 56%.
Negative predictive value: 89%.
Diagnostic performance of EUS elastography in diagnosing pancreatic ductal adenocarcinoma
Sensitivity: 96%.
Specificity: 64%.
Positive predictive value: 45%.
Negative predictive value: 98%.